Cumberland Pharmaceuticals jumps on $100M Apotex transaction [Yahoo! Finance]
Cumberland Pharmaceuticals Inc. (CPIX)
Last cumberland pharmaceuticals inc. earnings: 3/18 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investor.shareholder.com/cpix/index.cfm
Company Research
Source: Yahoo! Finance
Deal structure and terms Under the agreement, Apotex will purchase Cumberland's portfolio of branded pharmaceutical products for $100 million in cash. The transaction remains subject to approval by Cumberland's shareholders. Following completion, Cumberland will retain its development pipeline as well as its majority stake in Cumberland Emerging Technologies Inc., shifting its focus toward advancing its drug candidates. CEO highlights strategic shift “This transaction unlocks value for our shareholders and enables us to focus on the large market opportunities associated with our pipeline product candidates,” said A.J. Kazimi, Chief Executive Officer. Focus on pipeline development The Nashville-based company is advancing ifetroban, a thromboxane receptor antagonist, across several clinical programs targeting areas of unmet medical need. Cumberland recently reported positive Phase II results for ifetroban in patients with cardiomyopathy linked to Duchenne muscular dystrop
Show less
Read more
Impact Snapshot
Event Time:
CPIX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CPIX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CPIX alerts
High impacting Cumberland Pharmaceuticals Inc. news events
Weekly update
A roundup of the hottest topics
CPIX
News
- CUMBERLAND PHARMACEUTICALS TO ANNOUNCE Q1 2026 FINANCIAL RESULTS & COMPANY UPDATEPR Newswire
- Cumberland Pharmaceuticals Announces Strategic Transaction to Integrate Commercial Business with ApotexPR Newswire
- CUMBERLAND PHARMACEUTICALS ANNOUNCES EXPANDED INDICATION FOR CALDOLOR® (IBUPROFEN) INJECTION AND LAUNCH OF NEW BRAND WEBSITEPR Newswire
- Cumberland Pharmaceuticals Launches New Sancuso® Website Featuring Educational Resources for Chemotherapy-Induced Nausea and VomitingPR Newswire
- Cumberland Pharmaceuticals Inc (CPIX) Q4 2025 Earnings Call Highlights: Revenue Surge and ... [Yahoo! Finance]Yahoo! Finance
CPIX
Sec Filings
- 4/24/26 - Form 8-K
- 4/23/26 - Form DEFA14A
- 4/23/26 - Form 8-K
- CPIX's page on the SEC website